Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers

AuthID
P-00W-ZW2
5
Author(s)
Krolewiecki, A
·
Pinto, F
·
Gold, S
·
Munoz, J
Document Type
Article
Year published
2022
Published
in FRONTIERS IN PHARMACOLOGY, ISSN: 1663-9812
Volume: 13
Indexing
Publication Identifiers
Pubmed: 35910353
SCOPUS: 2-s2.0-85135162025
Wos: WOS:000834109800001
Source Identifiers
ISSN: 1663-9812
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.